Product Code: GVR-4-68039-919-5
North America Disposable Endoscopes Market Growth & Trends:
The global North America disposable endoscopes market size is expected to reach USD 2.01 billion by 2030, registering a CAGR of 7.85% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of infection due to reusable endoscopes in the hospitals and the growing preference for disposable endoscope components are some of the major factors anticipated to drive the market growth over the forecast years. In addition, cleaning and disinfecting disposable endoscopes and their accessories to eliminate the disease transmission risk is a very tedious task for medical professionals.
The increasing number of endoscopic procedures and the growing prevalence of several chronic diseases are also further expected to accelerate the market growth. The lack of reprocessing and drying practices by the medical staff increases the chance of contamination which in turn drives the single-use endoscopes adoption. For instance, the data published in the American Journal of Infection Control stated that about 71% of the reusable endoscopes sample found microbial growth. The bronchoscopy segment dominated the market by application in 2021 with a revenue share of 29.3%. Flexible bronchoscopes play a critical role in the therapeutic and diagnostic management of several pulmonary disorders and better procedural outcomes.
The growing adoption of bronchoscopes for the diagnosis of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is expected to drive the segment growth. Increasing COVID-19 cases and the fear of disease transmission due to the use of reusable bronchoscopes also boosted the single-use bronchoscope adoption. For instance, according to World Health Organization (WHO), the number of COVID-19 cases has increased to over 74.8 million by February 2022 in the United States of America. The hospital segment dominated the market and accounted for a revenue share of 47.5% in 2021 owing to the increasing number of endoscopic procedures performed in the hospitals and growing patient preference to visit the hospital for disease diagnosis.
However, the fastest growth is expected from the clinics segment over the forecast period owing to the increasing preference to use single-use endoscopic devices to reduce the risk of contamination, lower the procedure cost, and better clinical outcomes. In addition, an increasing number of clinics that performed endoscopic procedures in the U.S also anticipated supporting high growth of the segment. The COVID-19 pandemic has positively impacted the growth of the market. The benefit of using a disposable endoscope to minimize the risk of disease transmission increased its adoption during the COVID-19 period.
Increasing regulatory approval and strategic initiatives by the manufacturers to innovate new endoscopic devices to meet the consumer's needs, in turn, supported the growth of the market. For instance, in July 2020 a medical device manufacturer, Ambu Inc., got U.S. FDA 510(k) approval for its sterile single-use duodenoscope device. The device includes "aScope Duodeno" which is a single-use endoscope and "aBox Duodeno" a reusable processor unit to treat and diagnose several disease conditions like cancer, tumors, pancreatitis, and gallstones, in the bile duct and pancreas.
North America Disposable Endoscopes Market Report Highlights:
- The gastrointestinal endoscopes segment dominated the market with revenue share of 56.6% in 2024. The U.S. dominated the disposable endoscopes market in North America in 2024.
- The laparoscopes segment is expected to witness fastest CAGR growth during the forecast period. The U.S. FDA recently approved various disposable bronchoscopes, which are anticipated to increase the availability of these devices in the market and drive segment growth.
- The outpatient facilities' segment dominated the market in 2024 and accounted for the largest revenue share of 53.3%. Favorable government initiatives and reimbursement policies boost the segment growth.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Country scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. End Use outlook
- 2.2.3. Country outlook
- 2.3. Competitive Insights
Chapter 3. North America Disposable Endoscopes Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.2.3. Industry challenges
- 3.3. North America Disposable Endoscopes: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
- 3.4. Reimbursement Framework
Chapter 4. North America Disposable Endoscopes Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Type Market Share Analysis, 2024 & 2030
- 4.3. Segment Dashboard
- 4.4. North America Disposable Endoscopes Market, by Type, 2018 to 2030
- 4.5. Laparoscopes
- 4.5.1. Laparoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Arthroscopes
- 4.6.1. Arthroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Ureteroscopes
- 4.7.1. Ureteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.8. Cystoscopes
- 4.8.1. Cystoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.9. Gynecology Endoscopes
- 4.9.1. Gynecology Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.10. Neuroendoscopes Disposable Endoscopes
- 4.10.1. Neuroendoscopes estimates and forecasts, 2018 to 2030 (USD Million)
- 4.11. Bronchoscopes
- 4.11.1. Bronchoscopes estimates and forecasts, 2018 to 2030 (USD Million)
- 4.12. Hysteroscopes
- 4.12.1. Hysteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.13. Laryngoscopes
- 4.13.1. Laryngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.14. Otoscopes
- 4.14.1. Otoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.15. Nasopharyngoscopes
- 4.15.1. Nasopharyngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.16. Rhinoscopes
- 4.16.1. Rhinoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.17. Gastrointestinal North America Disposable Endoscopes
- 4.17.1. Gastrointestinal North America Disposable Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.17.2. Gastroscope (Upper GI Endoscope)
- 4.17.2.1. Gastroscope (Upper GI Endoscope) market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.17.3. Enteroscope
- 4.17.3.1. Enteroscope market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.17.4. Duodenoscope
- 4.17.4.1. Duodenoscope market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.17.5. Colonoscope
- 4.17.5.1. Colonoscope market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. North America Disposable Endoscopes Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. End Use Market Share Analysis, 2024 & 2030
- 5.3. Segment Dashboard
- 5.4. North America Disposable Endoscopes Market, by End Use, 2018 to 2030
- 5.5. Hospitals
- 5.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Outpatient facilities
- 5.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Region, By Product, By End Use, 2018- 2030 (USD Million)
- 6.1. Country Market Share Analysis, 2024 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Regional Market Snapshot
- 6.4. North America Disposable Endoscopes Market Share by Region, 2024 & 2030:
- 6.5. North America
- 6.5.1. North America disposable endoscopes market, 2018 - 2030 (USD Million)
- 6.5.2. U.S.
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. U.S. disposable endoscopes market, 2018 - 2030 (USD Million)
- 6.5.3. Canada
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. Canada disposable endoscopes market, 2018 - 2030 (USD Million)
- 6.5.4. Mexico
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. Mexico disposable endoscopes market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Profiles
- 7.3.1. Olympus Corporation
- 7.3.1.1. Company overview
- 7.3.1.2. Financial performance
- 7.3.1.3. Product benchmarking
- 7.3.1.4. Strategic initiatives
- 7.3.2. Boston Scientific Corporation
- 7.3.2.1. Company overview
- 7.3.2.2. Financial performance
- 7.3.2.3. Product benchmarking
- 7.3.2.4. Strategic initiatives
- 7.3.3. PENTAX Medical (Hoya Corporation)
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. FUJIFILM Holdings Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Karl Storz GmbH & Co., KG
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Stryker
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Medtronic
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Ambu A/S.
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. STERIS plc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives